poziotinib
poziotinib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| SPECTRUM PHARMACEUTICALS INC (SPPI) | Phase 3 |
Clinical Trials (1)
A Randomized, Phase 3 Study of Poziotinib in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring HER2 Exon 20 Mutations (PINNACLE)
Frequently asked questions
Who is developing poziotinib?
poziotinib is being developed by SPECTRUM PHARMACEUTICALS INC.
How many clinical trials involve poziotinib?
BioSniper tracks 1 clinical trial involving poziotinib.
Get deeper analysis on poziotinib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis